Publications and Presentations

Publications and presentations from fellows in the Hematology Oncology division.

2025-2026

Max Greenberg:

  • Raul Vazquez-Urrutia J, Greenberg M, Zhu J, Takamori S, Komiya T. Prognostic Implications of Timing of Immunotherapy in Stage IV Non-Small Cell Lung Cancer. Original Article World J Oncol. 1924;000(000):0-000. doi:10.14740/wjon1924
  • Hu H, Piotrowska Z, Hare, et al. Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms. Cancer Cell. 2021. doi: 10.1016/j.ccell.2021.09.003.
  • Benboujja F, Greenberg M, Nourmahnad A, Rath N, Hartnick C. Evaluation of the Human Vocal Fold Lamina Propria Development Using Optical Coherence Tomography. Laryngoscope. 2021. doi:10.1002/lary.29516 
  • Raoof S, Mulford IJ, Frisco-Cabanos H, et al. Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer. Oncogene. 2019. doi:10.1038/s41388-019-0887-2  Greenberg M, Caloway C, Hersh C, Ryan D, Goldenberg P, Hartnick C. Pharyngeal flap using carotid artery mobilization in 22q11.2 deletion syndrome with velopharyngeal insufficiency. Int J Pediatr Otorhinolaryngol. 2019;120(May):130-133. doi:10.1016/j.ijporl.2019.02.010  
  • Misale S, Fatherree JP, Cortez E, et al. KRAS G12C NSCLC models are sensitive to direct targeting of KRAS in combination with PI3K inhibition. Clin Cancer Res. 2018;(14):clincanres.0368.2018. doi:10.1158/1078-0432.CCR-18-0368 
  • Dastur A, Choi Ah, Costa C, et al. NOTCH1 represses MCL-1 levels in GSI-resistant T-ALL, making them susceptible to ABT-263. Clin Cancer Res. 2018:clincanres.0867.2018. doi:10.1158/1078-0432.CCR-18-0867 
  • Kodack DP, Farago AF, Dastur A, et al. Primary Patient-Derived Cancer Cells and Their Potential for  Personalized Cancer Patient Care. Cell Rep. 2017;21(11):3298-3309. doi:10.1016/j.celrep.2017.11.051 
  • Liu T, Greenberg M, Wentland C, et al. PD-L1 expression and CD8+ infiltration shows heterogeneity in juvenile recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2017;95:133-138. doi:10.1016/j.ijporl.2017.02.022  

Gautam Shrivastava:
Oral Presentations

  • Shrivastava GA, Jarboe J, Ahmed A, et al. Pathologic response rates after neoadjuvant therapy for soft-tissue sarcoma. In: proceedings from the American Society for Radiation Oncology; September 15 – September 18, 2019; Chicago, IL. Abstract 3873.

Poster Presentations

  • Nurse D.P, Zabor E.C., Cancilla D, Abdallah K, Adcock B, Batah H, Zureigat H, Rauf A, Shrivastava GA, Nakitandwe J, Chen M, Younes IE, Ingrahm A, Jain AG, Balderman S, Singh A, Advani AS, Carraway HE, Gerds AT, Mustafa Ali MK. Outcomes of blast-phase MPN and JAK2, MPL, and CALRmutated de novo AML: A propensity score-adjusted cohort study. JCO 42, 6526-6526(2024).DOI:10.1200/JCO.2024.42.16_suppl.6526
  • Sheu, M., Garcia, S. M., Patel, M., Shrivastava, G., Orland, M., Crilley, A., Hamilton, B.K., Anwer, F. & Majeed, A. (2023). Yield of Repeat Blood Cultures in Acute Myeloid Leukemia Patients Following Allogeneic Hematopoietic Stem Cell Transplantation. Blood, 142, 5102. 
  • Orland, M., Sheu, M., Patel, M., Adcock, B., Ardila, V., Shrivastava, G., Garcia S.M. & Majeed, A. (2023). Infectious Complications and Mortality in Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation: Experiences of 10 Years in a Single Center. Blood, 142, 4404.
  • Seldon C & Grossman J, Shrivastava GA, Fernandez M et al. CivaSheet® Use for Recurrent Soft Tissue Sarcoma: A Single Institution Experience. In: Connective Tissue Oncology Society Annual meeting; November 10 – 13, 2021; Virtual. Abstract 1819055.
  • Seldon, C., Grosso, J., Subhawong, T., Shrivastava, G., Fernandez, M., Yechieli, R., & Mason, M. (2021, October). MRI Radiomics Features Correlate with Histologic Tumor Necrosis Following Neoadjuvant Radiation Therapy in Extremity Soft Tissue Sarcoma. In American Journal of Clinical Oncology – Cancer Trials (Vol. 44, No. 10, pp. S131-S131) Al-Awady A, Seldon C, Shrivastava GA, et al. Survival Disparities in the Adolescent and Young Adult (AYA) Population with Extremity Sarcoma: A NCBD Analysis. In: Eastern-Atlantic Research Forum; February 19 – 21, 2021; Virtual.
  • Seldon C, Shrivastava GA, Jarboe J, et al. Tumor necrosis following multi-modality neoadjuvant therapy for sarcoma: a single institution series. In: proceedings from the American Society for Radiation Oncology; October 24 – 28, 2020; Virtual. Abstract 2020.
  • Shrivastava GA, Jarboe J, Ahmed A, et al. Pathologic response rates after neoadjuvant therapy for soft-tissue sarcoma. In: proceedings from the American Society of Clinical Oncology; May 31 – June 4, 2019; Chicago, IL. Abstract 11060Shrivastava 4
  • Shrivastava GA, Jarboe J, Ahmed A, et al. Pathologic response rates after neoadjuvant therapy for sarcoma. In: proceedings from the Zubrod Memorial Lecture and Sylvester Cancer Research Symposium; April 12, 2019; Miami, FL. Abstract 67.

Publications:

  • Kundu R, Chatterjee A, Nathani A, Shrivastava G, Bhavsar S, Chaisson N. Type A versus type B Lactic Acidosis in the context of undiagnosed B-cell lymphoma. BMJ Case Rep. 2025 Jun 12;18(6):e264218. doi: 10.1136/bcr-2024-264218. PMID: 40506102.
  • Sheu M, Molina Garcia S, Shrivastava G, et al. Yield of repeat blood cultures in acute myeloid leukemia patients with febrile neutropenia and bacteremia following allogeneic hematopoietic stem cell transplant. Transpl Infect Dis. 2024; 26:e14345. https://doi.org/10.1111/tid.14345
  • Seldon C, Grossman JG, Shrivastava G, Fernandez M, Jin W, Conaway S, Rosenberg A, Livingstone A, Franceschi D, Jonczak E, Trent J, Subhawong T, Studenski MT, Yechieli R. CivaSheet® use for soft tissue sarcoma: A single institution experience. Brachytherapy. 2023 Sep-Oct;22(5):649-654. doi: 10.1016/j.brachy.2023.03.001. Epub 2023 Jun 2. PMID: 37271655.
  • Seldon C, Shrivastava G, Al-Awady A, Asher D, Ramey S, Fernandez M, Dooley S, Kwon D, Zhao W, Goel N, Diwanji T, Subhawong T, Trent J, Yechieli R. Variation in Management of Extremity Soft-Tissue Sarcoma in Younger vs Older Adults. JAMA Netw Open. 2021;4(8): e2120951. doi:10.1001/jamanetworkopen.2021.20951
  • Seldon C, Shrivastava G, Fernandez M, Jarboe J, Conway S, Pretell J, Freedman L, Wolfson A, Zhao W, Kwon D, Rosenberg A, Subhawong T, Trent J, Yechieli R. Pathologic Response Rates after Neoadjuvant Therapy for Sarcoma: A Single Institution Study. Cancers. 2021; 13(5):1074. https://doi.org/10.3390/cancers13051074

2024-2025

Suguna Raju: 

  • Recipient of ASH Medical Educators Institute (MEI) Award (2024-2025). Preceptor: Dr. Christina Lee. 
  • Premature Immune Aging in Survivors of Childhood Hematologic Malignancies. Presented at: 66th ASH Conference.

Andrea Rivera: Prospective Study of CLL1 and CD45RA As Biomarkers of Leukemic Stem Cells to Predict Therapeutic Response in Acute Myeloid Leukemia. Presented at:  66th ASH Conference.

Luke Li:  Analysis of Trends in Race and Gender Disparities in the Incidence of Pheochromocytoma from 2000 to 2020. Presented at: 2025 ASCO Annual Meeting.

Alex Winter & Sonia Yu: Analysis of Trends in Race and Gender Disparities in the Incidence of Osteosarcoma, Leiomyosarcoma and Ewing sarcoma from 2000 to 2021.  Presented at: 2025 ASCO Annual Meeting.

Changtai Tian: 

  • Low Dose Methotrexate Resulting in Pancytopenia: A Case Report. Presented at: Stony Brook Women in Medicine Conference 2025. 
  • Pulmonary Lymphangitic Carcinomatosis as a Manifestation of Gastric Cancer in a Young Adult. Presented at: Stony Brook Women in Medicine Conference 2025.
  • Tian C, Alvarado R, Kim T, Slostad J. Male ductal carcinoma in situ: diagnosis and management of a rare disease in men. BMJ Case Rep. 2024 Mar 18.

2023-2024

Alessandra Petrillo 

  • Educating and empowering health care teams to recognize and intervene on cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in patients on bispecific t-cell engager therapy (BiTEs) who present to the hospital - A Quality Improvement Study. Presented at: Stony Brook Women in Medicine Conference 2024.
  • Petrillo, A., Seog, W., Halterman, J., Winter, A., Lee, C. Educating and empowering health care teams who present to the hospital to recognize and intervene on cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in patients on bispecific t-cell engager therapy (BiTEs): A quality improvement study. American Society of Clinical Oncology (ASCO) 2024/Chicago, Il, USA.

Alex Winter

  • Ying, J., Winter, A., Airola, K., Shen, B., Cohen, J., Biegnon, A., & Huang, C. Are 11C-vorozole and 18F-FDG uptake correlated in breast cancer? – a dual tracer study. Society of Nuclear Medicine and Molecular Imaging Annual Meeting 2023/Chicago, IL, USA.

2022-2023

Bassil Said

  • B. Said, A. Rashidi, A. Gill, K. Burrows, E. Huselton, J. Liesveld, S. Gill, O. A. (2023). Effects of hyperbaric oxygen therapy on salivary and fecal microbiota in patients with multiple myeloma undergoing autologous hematopoietic cell transplantation. European Society of BMT Annual Meeting, Paris, France. April, 2023.
  • B. Said, (2023). Never too soon to be thinking about heparin-induced thrombocytopenia! A case report of early onset heparin-induced thrombocytopenia. Blood Coagulation & Fibrinolysis, 10–1097.
  • Manogna, Dharmini, Lipof, J. J., Baran, A. M., Said, B., Becker, M. W., Mendler, J. H., Aljitawi, O. S., O’Dwyer, K. M., Huselton, E., & Burack, R. (2023). Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia. Journal of Geriatric Oncology, 14(1), 101403.
  • Said, Bassil, Ahmed, T., & Lee, C. Y. (2022). Increased Incidence Rate of Post-Transplant Lymphoproliferative Disorders (PTLD) Following the COVID-19 Pandemic: A Single Center Experience. Blood, 140(Supplement 1), 12083–12084.
  • Pendela, Venkata Satish, Said, B., Kudaravalli, P., Chhabria, M., Manogna, D., & Gurell, M. (2022). Interstitial Pneumonitis—A Newly Recognized Consequence of Intravesical Gemcitabine Therapy. American Journal of Therapeutics, 29(6), e752–e754.

Alessandra Petrillo

  • Petrillo, A. Ip, A. Della Pia A. Gill, S. Zenreich, J. Gutierrez, M. McNeill, A. Feldman, T. Lelsie, L. Goy, A. Phase 1b dose finding study of venetoclax with ibrutinib and  rituximab in patients with relapsed/refractory diffuse large b-cell lymphoma(DLBCL). HemaSphere. Apr 2022.
  • Petrillo, A. Albitar, M. Feldman, T. Complete response of adult T-cell lymphoma leukemia to a Bcl-2 inhibitor: A case report. Annals of Lymphoma. Mar 2022.  

2021-2022

Sonia Yu 

  • Myer, A; Yu, S. A Rare Cause of Abdominal Pain and Splenomegaly: Primary Splenic Diffuse Large B-Cell Lymphoma. Abstract published at Society of Hospital Medicine Converge 2021. Abstract 581 Journal of Hospital Medicine.
  • Yu, Sonia. Oentoro, Jaymie. Paroxysmal Nocturnal Hemoglobinuria Presenting as Ischemic Stroke. Abstract presented at the New York Chapter ACP 2022 Scientific Meeting Poster Competition.

2020-2021

Judy Huang & Alex Carvajal

  • Huang, J., Carvajal, A., Wu, S. Tolerability of single agent nivolumab in cancer patients: a meta-analysis [abstract]. In: Journal of Clinical Oncology; 2020 May 25. 
  • Carvajal, A., Huang, J., Wu, S. Tolerability of dual checkpoint blockade with nivolumab and ipilimumab: a meta-analysis [abstract]. In: Journal of Clinical Oncology; 2020 May 25. 

Bassil Said

  • Said, Bassil, Forsyth, A., Solimeno, L. P., Kouides, P. A., & Poudyal, B. S. (2021). Surgical excision of a pseudotumour under the coverage of the plasma‐derived factor X concentrate in a patient with severe factor X deficiency: A case report. Haemophilia, 27(4), e543–e546. 

Alex Winter

  • Zucker, A., Winter, A., Lumley, D., Karwowski, P., Min-Kyung, J., & Kao, J. Prognostic role of baseline neutrophil-to-lymphocyte ratio in metastatic solid tumors. 2020/Molecular and Clinical Oncology, 13(4), 25.

2019-2020

Judy Huang

  • Bhasin, V., Gasimli-Gamache, L., Mathew, J., Illipparambil, L., Yoo, J., Lyu, A., Huang, J., Rajendren, S., Haghshenas, N., Wazed, B. “Lung Cancer Screening in Veterans Health Administration Ambulatory Resident Clinic.” Poster presented at 2019 Stony Brook University Hospital Internal Medicine Annual Research Day in Stony Brook, NY. 
  • Pan X, Chen Y, Biju B, Ahmed N, Kong J, Goldenberg M, Huang J, Mohan N, Klosek S, Parsa K, Guh CY, Lu R, Pickett HA, Chu HP, Zhang D. “FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops.” Sci Rep. 2019 Dec 13;9(1):19110.